STOCK TITAN

[Form 4] Gannett Co., Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Gannett Co., Inc. director John Jeffry Louis was granted 7,263 shares of common stock on 09/30/2025 as payment in lieu of a director retainer of $30,000. The shares were issued at a reported price of $4.13 and the filing shows 635,474 shares beneficially owned by the reporting person after the transaction. Several additional indirect holdings are listed, including 13,471 shares held in a Marital Trust and other trust interests totaling 13,351 shares. The grant was reported on a Form 4 signed by an attorney-in-fact on 10/02/2025 and is described as exempt under Rule 16b-3.

Il membro del consiglio di Gannett Co., Inc., John Jeffry Louis, ha ricevuto in pagamento in luogo di un compenso da direttore 7.263 azioni ordinarie in data 30/09/2025. Le azioni sono state emesse a un prezzo riportato di 4,13 dollari e la dichiarazione mostra 635.474 azioni beneficiariamente possedute dalla persona indicante dopo la transazione. Sono elencate diverse partecipazioni indirette, tra cui 13.471 azioni detenute in una Marital Trust e altri interessi fiduciari per un totale di 13.351 azioni. Il grant è stato riportato su un Modulo 4 firmato da un procuratore-in-fatto il 02/10/2025 ed è descritto come esente ai sensi della Regola 16b-3.
El director de Gannett Co., Inc., John Jeffry Louis, recibió 7,263 acciones comunes el 30/09/2025 como pago en lugar de un honorario de director de 30,000. Las acciones se emitieron a un precio reportado de 4,13 y el informe muestra 635,474 acciones beneficiariamente poseídas por la persona reportante después de la transacción. Se listan varias participaciones indirectas, incluyendo 13,471 acciones en un Marital Trust y otros intereses fiduciarios por un total de 13,351 acciones. La adjudicación fue reportada en un Formulario 4 firmado por un apoderado el 02/10/2025 y se describe como exenta bajo la Regla 16b-3.

Gannett Co., Inc.의 이사인 John Jeffry Louis가 이사 보수 대신 현금으로 $30,000의 대가를 받고 09/30/2025에 일반주 7,263주를 받았습니다. 주식은 보고된 가격 $4.13으로 발행되었으며, 보고서는 거래 후 피보고자의 유익상 소유 주식이 635,474주라고 기재합니다. 또한 13,471주가 Marital Trust에 보유되고 다른 신탁 이익이 합계 13,351주로 기재된 여러 차익 보유가 간접적으로 나열되어 있습니다. 이 보상은 16b-3 규칙에 따라 면제된 것으로 설명되며, 2025년 10/02/2025에 약속된 대리인에 의해 서명된 Form 4에 보고되었습니다.

Le directeur de Gannett Co., Inc., John Jeffry Louis, a reçu en paiement en lieu d'honoraires de directeur 7 263 actions ordinaires le 30/09/2025. Les actions ont été émises à un prix déclaré de 4,13 $ et le dépôt indique 635 474 actions détenues bénéficiairement par la personne déclarant après la transaction. Plusieurs détentions indirectes sont listées, y compris 13 471 actions détenues dans une Marital Trust et d'autres intérêts en fiducie totalisant 13 351 actions. La subvention a été déclarée sur un formulaire 4 signé par un mandataire le 02/10/2025 et est décrite comme exonérée en vertu de la règle 16b-3.
Director der Gannett Co., Inc., John Jeffry Louis, erhielt 7.263 Stammaktien am 30.09.2025 als Zahlung statt einer Direktoren-Gebühr von 30.000 $. Die Aktien wurden zu einem gemeldeten Preis von 4,13 $ ausgegeben, und die Einreichung zeigt 635.474 Aktien, die von der meldenden Person nach der Transaktion vorteilhaft besessen werden. Mehrere weitere indirekte Beteiligungen sind aufgeführt, darunter 13.471 Aktien, die in einem Marital Trust gehalten werden, und andere Treuhandanteile summieren sich auf 13.351 Aktien. Die Gewährung wurde in einem Formular 4 berichtet, das von einem Bevollmächtigten am 02.10.2025 unterschrieben wurde und als gemäß Regel 16b-3 befreit beschrieben wird.
مدير شركة Gannett Co., Inc.، جون جيفري لويس، حصل على 7,263 سهماً عادياً كتعويض بدلاً من أتعاب المدير بتاريخ 30/09/2025. تم إصدار الأسهم بسعر معلَن قدره 4.13 دولار، وتُظهر الرسالة أن الشخص المبلغ يمتلك بعد الصفقة 635,474 سهماً بصفة مستفيدة. كذلك تم سرد العديد من الحيازات غير المباشرة، بما في ذلك 13,471 سهماً مملوكة في Marital Trust وغيرها من المصالح الثقة بإجمالي 13,351 سهماً. تم الإبلاغ عن المنحة في نموذج 4 موقّع من قبل وكيل فعلي في 02/10/2025 ووصف بأنه معفى بموجب القاعدة 16b-3.
Gannett Co., Inc. 的董事 John Jeffry Louis 获得 7,263 股普通股,作为以董事费用形式的报酬,日期为 2025/09/30,代替 30,000 美元的董事报酬。股票按公开披露的价格 4.13 美元发行,申报人交易后实际持有的受益所有权股票为 635,474 股。另有若干间接持股,包含 13,471 股由婚姻信托(Marital Trust)持有,及其他信托利益合计 13,351 股。此次授予在经代理人签署的 Form 4(2025/10/02)上报道,被描述为依据规则 16b-3 免税。
Positive
  • None.
Negative
  • None.
Il membro del consiglio di Gannett Co., Inc., John Jeffry Louis, ha ricevuto in pagamento in luogo di un compenso da direttore 7.263 azioni ordinarie in data 30/09/2025. Le azioni sono state emesse a un prezzo riportato di 4,13 dollari e la dichiarazione mostra 635.474 azioni beneficiariamente possedute dalla persona indicante dopo la transazione. Sono elencate diverse partecipazioni indirette, tra cui 13.471 azioni detenute in una Marital Trust e altri interessi fiduciari per un totale di 13.351 azioni. Il grant è stato riportato su un Modulo 4 firmato da un procuratore-in-fatto il 02/10/2025 ed è descritto come esente ai sensi della Regola 16b-3.
El director de Gannett Co., Inc., John Jeffry Louis, recibió 7,263 acciones comunes el 30/09/2025 como pago en lugar de un honorario de director de 30,000. Las acciones se emitieron a un precio reportado de 4,13 y el informe muestra 635,474 acciones beneficiariamente poseídas por la persona reportante después de la transacción. Se listan varias participaciones indirectas, incluyendo 13,471 acciones en un Marital Trust y otros intereses fiduciarios por un total de 13,351 acciones. La adjudicación fue reportada en un Formulario 4 firmado por un apoderado el 02/10/2025 y se describe como exenta bajo la Regla 16b-3.

Gannett Co., Inc.의 이사인 John Jeffry Louis가 이사 보수 대신 현금으로 $30,000의 대가를 받고 09/30/2025에 일반주 7,263주를 받았습니다. 주식은 보고된 가격 $4.13으로 발행되었으며, 보고서는 거래 후 피보고자의 유익상 소유 주식이 635,474주라고 기재합니다. 또한 13,471주가 Marital Trust에 보유되고 다른 신탁 이익이 합계 13,351주로 기재된 여러 차익 보유가 간접적으로 나열되어 있습니다. 이 보상은 16b-3 규칙에 따라 면제된 것으로 설명되며, 2025년 10/02/2025에 약속된 대리인에 의해 서명된 Form 4에 보고되었습니다.

Le directeur de Gannett Co., Inc., John Jeffry Louis, a reçu en paiement en lieu d'honoraires de directeur 7 263 actions ordinaires le 30/09/2025. Les actions ont été émises à un prix déclaré de 4,13 $ et le dépôt indique 635 474 actions détenues bénéficiairement par la personne déclarant après la transaction. Plusieurs détentions indirectes sont listées, y compris 13 471 actions détenues dans une Marital Trust et d'autres intérêts en fiducie totalisant 13 351 actions. La subvention a été déclarée sur un formulaire 4 signé par un mandataire le 02/10/2025 et est décrite comme exonérée en vertu de la règle 16b-3.
Director der Gannett Co., Inc., John Jeffry Louis, erhielt 7.263 Stammaktien am 30.09.2025 als Zahlung statt einer Direktoren-Gebühr von 30.000 $. Die Aktien wurden zu einem gemeldeten Preis von 4,13 $ ausgegeben, und die Einreichung zeigt 635.474 Aktien, die von der meldenden Person nach der Transaktion vorteilhaft besessen werden. Mehrere weitere indirekte Beteiligungen sind aufgeführt, darunter 13.471 Aktien, die in einem Marital Trust gehalten werden, und andere Treuhandanteile summieren sich auf 13.351 Aktien. Die Gewährung wurde in einem Formular 4 berichtet, das von einem Bevollmächtigten am 02.10.2025 unterschrieben wurde und als gemäß Regel 16b-3 befreit beschrieben wird.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Louis John Jeffry

(Last) (First) (Middle)
C/O GANNETT CO., INC.
175 SULLY'S TRAIL, SUITE 203

(Street)
PITTSFORD NY 14534

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Gannett Co., Inc. [ GCI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/30/2025 A 7,263(1) A $4.13 635,474 D
Common Stock 13,471 I Marital Trust U/A John J. Louis, Jr. Trust
Common Stock 3,478 I John J. Louis, Jr. Trust under the Will of John J. Louis fbo Tracy L. Merrill
Common Stock 9,873 I John Jeffry Louis, Jr. Trust under the Will of John J. Louis fbo John Jeffry Louis
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects shares of common stock granted in lieu of retainer fees of $30,000 issued in a transaction exempt under Rule 16b-3.
Remarks:
/s/ Polly Grunfeld Sack, Attorney-in-Fact for John Jeffry Louis 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Gannett director John Jeffry Louis report on Form 4 (GCI)?

The Form 4 reports a grant of 7,263 shares of common stock issued on 09/30/2025 in lieu of a $30,000 retainer.

At what price were the shares issued according to the Form 4 for GCI?

The shares are reported at a price of $4.13 per share on the Form 4.

How many shares does the reporting person beneficially own after the transaction?

Following the reported transaction, the Form 4 shows 635,474 shares beneficially owned by the reporting person.

Was the issuance of shares reported as exempt under any rule on the Form 4?

Yes. The Form 4 states the shares were issued in a transaction exempt under Rule 16b-3.

Who signed the Form 4 filing for John Jeffry Louis and when?

The Form 4 was signed by Polly Grunfeld Sack, Attorney-in-Fact, and dated 10/02/2025.
Gannett Co Inc

NYSE:GCI

GCI Rankings

GCI Latest News

GCI Latest SEC Filings

GCI Stock Data

520.49M
139.12M
5.11%
85.81%
10.81%
Publishing
Newspapers: Publishing Or Publishing & Printing
Link
United States
PITTSFORD